(Q37260210)

19 August 2017

1 reference

title

Ganglioside antibodies and neuropathies (English)

1 reference

19 August 2017

1 reference

Simon Rinaldi

1

0 references

author name string

Hugh J Willison

series ordinal

2

1 reference

19 August 2017

publication date

1 October 2008

1 reference

Current Opinion in Neurology

19 August 2017

published in

1 reference

19 August 2017

volume

21

1 reference

19 August 2017

issue

5

1 reference

19 August 2017

page(s)

540-546

1 reference

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

19 August 2017

cites work

2 references

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PONE.0000344

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Chronic inflammatory demyelinating polyneuropathies: current treatment strategies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Immunotherapy for Guillain-Barre syndrome: a systematic review

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Serum antibodies to gangliosides in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

PCR-restriction fragment length polymorphism analysis of Campylobacter jejuni genes involved in lipooligosaccharide biosynthesis identifies putative molecular markers for Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Molecular mimicry in Campylobacter jejuni: role of the lipo-oligosaccharide core oligosaccharide in inducing anti-ganglioside antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Origin of ganglioside complex antibodies in Guillain–Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Polymorphisms of CD1 genes in chronic dysimmune neuropathies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Time course of axonal regeneration in acute motor axonal neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Severe Guillain–Barré syndrome associated with chromosome 17p11.2-12 duplication

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Ganglioside mimicry and peripheral nerve disease

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Comparative genomic analysis of Campylobacter jejuni associated with Guillain-Barré and Miller Fisher syndromes: neuropathogenic and enteritis-associated isolates can share high levels of genomic similarity

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

From bench to bedside--experimental rationale for immune-specific therapies in the inflamed peripheral nerve

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Recognition characteristics of monoclonal antibodies that are cross-reactive with gangliosides and lipooligosaccharide from Campylobacter jejuni strains associated with Guillain-Barré and Fisher syndromes

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Multifocal motor neuropathy: the diagnostic spectrum and response to treatment

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Fisher/Gullain–Barré overlap syndrome in advanced AIDS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Cutting edge: Guillain-Barre syndrome-associated IgG responses to gangliosides are generated independently of CD1 function in mice

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Apoptosis of primary sensory neurons in GD1b-induced sensory ataxic neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Coexistent hereditary and inflammatory neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Anti-ganglioside complex antibodies associated with severe disability in GBS

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Anti-ganglioside antibodies alter presynaptic release and calcium influx

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

AHaemophilus influenzaeStrain Associated with Fisher Syndrome Expresses a Novel Disialylated Ganglioside Mimic†

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Cortico-hypoglossal and corticospinal conduction abnormality in Bickerstaff's brainstem encephalitis

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Patterns of Guillain-Barre syndrome in children: results from a Mexican population

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Lewis rats immunized with GM1 ganglioside do not develop peripheral neuropathy

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers.

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1097/WCO.0B013E32830B84B7

Identifiers

DOI

10.1097/WCO.0B013E32830B84B7

1 reference

19 August 2017

1 reference